NCT01582932 2019-01-22Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque PsoriasisMayne Pharma International Pty LtdPhase 1 Completed36 enrolled